Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

lebrikizumab

A humanized monoclonal antibody against interleukin 13 (IL-13) with immunosuppressive and anti-asthmatic activities. Lebrikizumab binds to IL-13 and inhibits IL-13-mediated pathways. IL-13, a cytokine mainly secreted by type 2 helper T cells, plays a key role in the induction of allergic inflammation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-IL-13 humanized monoclonal antibody TNX-650
immunoglobulin G4, anti-(human interleukin 13) (human-mouse monoclonal MILR1444a gamma-4-chain), disulfide with human-mouse monoclonal MILR1444a kappa-chain, dimer
monoclonal antibody TNX-650
Abbreviation:TNX-650
Code name:MILR1444A
PRO301444
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search